Bold truth: Giancarlo Stanton’s health may be the Yankees’ biggest question mark this season. And this is where it gets controversial: can a star who can swing a bat at all truly impact a lineup that’s hoping to compete in a crowded American League? Here’s a clearer, fully unique take on the latest update.
Giancarlo Stanton, designated hitter for the New York Yankees, continues to battle through the effects of epicondylitis—commonly known as tennis elbow—in both arms. Despite this ongoing pain, he remains determined to contribute, but his spring training presence has been limited. The latest reports confirm he has not yet appeared in any spring action and is only participating at a very restricted level, especially in the team’s pantry tasks and warmups.
Stanton, 36, produced 24 home runs across 77 games last season, yet he did not take the field in a game until June. Since 2018, when he first joined the Yankees, he has only surpassed 420 at-bats in a single season (510 at-bats in 2021), highlighting how injuries have continually limited his workload. His path to regular, full-time play remains fluid as he assesses his readiness for a full slate.
An upcoming exhibition game against Team Panama as part of a World Baseball Classic tune-up could offer a crucial preview. Opening Day is scheduled for March 25 in San Francisco, and Stanton has indicated he expects to be in the lineup after a couple of weeks of steady at-bats. His message to teammates and fans has been simple: he wants to be in the box and keep swinging, even if progress comes in small steps.
In practical terms, the Yankees are counting on Stanton to provide power and veteran leadership, but they must also manage his workload carefully to avoid aggravating the elbow condition. The team’s performance this season may hinge on how effectively he can contribute when available, and how well the supporting cast compensates during his inevitable rest periods.
Consider this a broader reflection: a star’s health can redefine a franchise’s arc when other pieces around him are still developing. If Stanton can find durability, he could anchor a New York lineup that is eager to prove it can compete at a high level. If not, the burden shifts to younger players to step up and fill the gaps.
What do you think should be the Yankees’ plan if Stanton remains on a limited schedule? Should they prioritize long-term elbow health over short-term power, or push for aggressive rehab and extended spring work to accelerate his readiness? Share your thoughts in the comments.